Cara Therapeutics Inc. sell StockNews.com
Start price
17.02.24
/
50%
€0.54
Target price
17.02.25
-
Performance (%)
-25.51%
End price
18.02.25
-
Summary
This prediction is currently being closed. The prediction for Cara Therapeutics Inc. shows a convincing performance of -25.51%. StockNews_com has a follow-up prediction for Cara Therapeutics Inc. where he still thinks Cara Therapeutics Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cara Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -3.141% | 1.269% | 16.367% |
| iShares Nasdaq 100 | -3.518% | -1.355% | 2.670% |
| iShares Nikkei 225® | -3.396% | 3.283% | 17.041% |
| iShares S&P 500 | -2.943% | -0.533% | 1.373% |
Comments by StockNews_com for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CARA provided by MarketBeat
In the thread Trading Cara Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten